Parshall B Lynne's Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed Apr 17, 2026
- Accession no.
- 0000874015-26-000172
- Filed
- Apr 17, 2026
- Trade date
- Apr 15, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $381.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Parshall B LynneCIK 0001073385 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | Common Stock | SSaleDisposed | −4,466 | $76.19 | −$340,264.54 | 51,878 | Direct | |
| Apr 15, 2026 | Common Stock | SSaleDisposed | −534 | $76.97 | −$41,101.98 | 51,344 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.